Send feedback

PRRT2 p.Pro152Arg

c.455C>G · rs760278435 · VCV1020513

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0988 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
episodic kinesigenic dyskinesia

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.0988likely benign
REVEL0.035moderately benign-leaning
SaProtLLR -10.89damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP 2.1GERP -0.001, phastCons 0.014
Regional constrainto/e 1.16unconstrained · MANE · 785 bp · p 0.003 · regional, not allelic
Overall
CADD17.49PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/75,028 alleles
Filtering AF 0.000247% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000159%
Overall 0.00062% 10/1,613,836 alleles · very rare exomes 10/1,461,572 · genomes 0/152,264 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0032% 31,243
African / African-Americangrpmax 0.00133% 75,028
European (non-Finnish) 0.000593% 168,543

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PRRT2
Protein
p.Pro152Arg
Coding
c.455C>G
MANE Select
NM_145239
dbSNP
rs760278435
Type
single nucleotide variant
Location
chr16:29813509 (GRCh38)
Full PRRT2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

episodic kinesigenic dyskinesia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Paroxysmal kinesigenic dyskinesia (Orphanet):

Inheritance
Autosomal dominant, Not applicable
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Worldwide)

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prrt2-p-pro152arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown